# MIMIVAX INC. — Form D

MIMIVAX INC. of BUFFALO, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-12. The offering totals $5.8M, of which $5.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-07-12
- Form: D
- Accession: 0002027238-24-000005
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $5.8M
- Amount sold: $5.8M
- Minimum investment: $10K
- Investors: 16
- Date of first sale: 2023-10-06
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-518591

## Issuer

- Name: MIMIVAX INC.
- CIK: 0002027238
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: ELM & CARLTON STREETS, BUFFALO, NY, 14263
- Phone: 7168535100

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Michael Ciesielski | Director | Buffalo, NY |
| Robert Fenstermaker | Director | Buffalo, NY |
| Scott Friedman | Director | Pittsburgh, PA |
| Jeremy Jacobs Jr. | Director | Buffalo, NY |
| Michael Sexton | Director | Buffalo, NY |
| Michael Ciesielski | Executive Officer | Buffalo, NY |

## More

- [CIK 2027238 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2027238&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002027238-24-000005.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.